Ethyl 2-mercaptopropionate
Common Name: |
Ethyl 2-mercaptopropionate |
IUPAC Name: |
ethyl 2-sulfanylpropanoate |
Molecular Formula: |
C9H18O3 |
SMILES: |
CCOC(=O)C(C)S |
Inchi: |
1S/C5H10O2S/c1-3-7-5(6)4(2)8/h4,8H,3H2,1-2H3 |
Inchi Key: |
LXXNWCFBZHKFPT-UHFFFAOYSA-N |
Cas No: |
19788-49-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
174.24 |
Mass (g/mol) |
134.04 |
Molar Refractivity |
47.82 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
7 |
Rings |
|
TPSA |
46.53 |
Hetero Atoms |
3 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
40.00 to 41.00 @ 1.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
1.382 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.89 |
LogP |
0.868 |
iLOGP |
2.52 |
XLOGP3 |
2.20 |
WLOGP |
1.49 |
MLOGP |
1.40 |
ESOL Log S |
-1.84 |
ESOL Solubility (mg/ml) |
2.49 |
ESOL Solubility (mol/l) |
0.014 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.81 |
Ali Solubility (mg/ml) |
0.27 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.84 |
Silicos-IT Solubility (mg/ml) |
2.54 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.80 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.365 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.055 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |